Common Shares Outstanding: The number of class A shares currently held by investors.
Atrium Therapeutics, Inc. (RNA) had Common Shares Outstanding of 17.11M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
19.64M |
|
-16.63M |
|
-- |
|
19.64M |
|
36.91M |
|
-17.28M |
|
0.65M |
|
-16.63M |
|
-16.63M |
|
-16.63M |
|
-16.63M |
|
-16.63M |
|
-16.63M |
|
-17.28M |
|
-17.13M |
|
17.11M |
|
17.11M |
|
-0.97 |
|
-0.97 |
|
| Balance Sheet Financials | |
285.56M |
|
4.34M |
|
6.79M |
|
292.36M |
|
21.91M |
|
-- |
|
36.35M |
|
58.26M |
|
234.10M |
|
234.10M |
|
234.10M |
|
|
Common Shares Outstanding |
17.11M |
| Cash Flow Statement Financials | |
-31.14M |
|
-2.10M |
|
301.50M |
|
-- |
|
268.26M |
|
268.26M |
|
12.21M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.04 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-88.01% |
|
-88.01% |
|
-- |
|
-84.71% |
|
-84.71% |
|
-33.24M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
1.31 |
|
68.75 |
|
-7.11% |
|
-7.11% |
|
-5.69% |
|
-7.11% |
|
13.69 |
|
-1.94 |
|
-1.82 |
|